MC4R and obesity due to melanocortin 4 receptor deficiency: Although, to date, treatment options for people with severe obesity due to MC4R deficiency have been limited, recent evidence suggests that the dual GLP-1 and GIP receptor agonist, tirzepatide, is effective at inducing weight loss in this group (see the accompanying paper by Bhatnagar et al.51).